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Obstetric transition in the World Health 
Organization Multicountry Survey on 
Maternal and Newborn Health: exploring 
pathways for maternal mortality reduction
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Carol J. Hogue,4 Rintaro Mori,5 Jun Zhang,6 Kapila Jayaratne,7 Ganchimeg Togoobaatar,5  
Cynthia Pileggi-Castro,8 Meghan Bohren,9 Joshua Peter Vogel,10 Özge Tunçalp,10 Olufemi  
Taiwo Oladapo,10 Ahmet Metin Gülmezoglu,10 Marleen Temmerman,10 and João Paulo Souza8
Objective. To test whether the proposed features of the Obstetric Transition Model—a 
theoretical framework that may explain gradual changes that countries experience as they 
eliminate avoidable maternal mortality—are observed in a large, multicountry, maternal and 
perinatal health database; and to discuss the dynamic process of maternal mortality reduction 
using this model as a theoretical framework.
Methods. This was a secondary analysis of a cross-sectional study by the World Health 
Organization that collected information on more than 300 000 women who delivered in 359 
health facilities in 29 countries in Africa, Asia, Latin America, and the Middle East, during 
a 2–4-month period in 2010–2011. The ratios of Potentially Life-Threatening Conditions, 
Severe Maternal Outcomes, Maternal Near Miss, and Maternal Death were estimated and 
stratified by stages of obstetric transition. The characteristics of each stage are defined. 
Results. Data from 314 623 women showed that female fertility, indirectly estimated by par-
ity, was higher in countries at a lower obstetric transition stage, ranging from a mean of 3 chil-
dren in Stage II to 1.8 children in Stage IV. Medicalization increased with obstetric transition 
stage. In Stage IV, women had 2.4 times the cesarean deliveries (15.3% in Stage II and 36.7% in 
Stage IV) and 2.6 times the labor inductions (7.1% in Stage II and 18.8% in Stage IV) as women 
in Stage II. The mean age of primiparous women also increased with stage. The occurrence of 
uterine rupture had a decreasing trend, dropping by 5.2 times, from 178 to 34 cases per 100 000 
live births, as a country transitioned from Stage II to IV.
Conclusions. This analysis supports the concept of obstetric transition using multicoun-
try data. The Obstetric Transition Model could provide justification for customizing strate-
gies for reducing maternal mortality according to a country’s stage in the obstetric transition.
Women’s health; maternal mortality, trends; obstetrics labor complications; maternal 
welfare, global health; World Health Organization.
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The year 2015 marks the end of the 
first global cycle of coordinated actions 
to promote human and social develop-
ment in the new millennium. This cycle 
began with the Millennium Declaration 
in 2000 (1), and since then, the govern-
ments of signatory countries, the United 
Nations and its specialized agencies, 
civil society, and many partners around 
the world have set in motion an unprec-
edented effort to achieve eight broad 
goals aimed at combatting extreme pov-
erty and promoting human develop-
ment (2). The Millennium Development 
Goals (MDG) initiative uses the year 
1990 as a baseline, and priorities in-
clude improvements in maternal and 
reproductive health. The fifth goal is to 
reduce the global maternal mortality ra-
tio (MMR) by 75% from levels observed 
in 1990, as well as to provide universal 
access to reproductive health care (2). 
MMR is a strong social indicator be-
cause it can reflect the living conditions 
of women, the level of population devel-
opment, and the quality and level of the 
health system organization (3).
The global MMR showed a significant 
decline recently, dropping from 380 in 
1990 to 210 in 2013, a reduction of ap-
proximately 45% (4). Nevertheless, this 
reduction is still below the original goal. 
There is a wide disparity among Regions, 
with MMR ranging from more than 1 000 
maternal deaths per 100 000 live births 
(LB) in some developing countries, to 
less than 10 per 100 000 LB in others. The 
estimated risk of a woman dying from 
causes associated with the pregnancy-
postpartum cycle in high-income coun-
tries is 1 in 3 400, compared to 1 in 52 in 
lower-income countries (4).
Despite all the global efforts, 2013 still 
recorded an estimated 289 000 maternal 
deaths, an alarming number (4). If this 
number of deaths were to occur in a sin-
gle episode, this would easily be recog-
nized as major tragedy. However, since 
maternal deaths are dispersed and occur 
mostly in poor and remote settings, of-
ten among ethnic minorities, they often 
go unnoticed by the public and the 
media. These fatalities have widespread 
magnitude, directly affecting families, 
resulting in a loss of structure and sta-
bility, and causing a great impact on 
the community. Sadly enough, the vast 
majority of maternal deaths could be 
avoided (3–5). 
A secular, worldwide trend towards 
social development and maternal mor-
tality reduction has been observed. The 
trend is more or less visible, depending 
on the country evaluated. Evolutionary 
changes in the pattern of MMR reduc-
tion, which can occur at a faster or slower 
pace, are known to be related to the 
amount and efficiency of government 
and societal efforts to implement public 
policies that promote social development 
and health improvement. This broad 
pattern includes a shift from maternal 
deaths predominantly due to direct ob-
stetric causes to deaths due to indirect 
causes; from deaths due to communi-
cable diseases to deaths caused by non-
communicable diseases; from a younger 
maternal population to an older one; and 
a decrease in MMR, along with an in-
crease in institutionalized maternity care, 
and eventually over-medicalization. We 
have called this phenomenon of gradual 
changes that countries experience in their 
pathway towards elimination of avoid-
able maternal mortality, the “obstetric 
transition” (6, 7). The proposed stages of 
obstetric transition are shown in Box 1. 
The main objective of this paper was 
to test whether the proposed features 
of the Obstetric Transition Model are 
observed in a large, multicountry, mater-
nal and perinatal health database (8, 9). 
Secondly, this study aimed to discuss the 
dynamic process of maternal mortality 
reduction using the Obstetric Transition 
Model as a theoretical framework. 
MATERIALS AND METHODS
This was a secondary analysis of the 
World Health Organization Multicoun-
try Survey on Maternal and Newborn 
Health 2010–2012 (WHO MCS); the 
methodology and details of the primary 
study are published elsewhere (8, 9). 
Briefly, the WHO MCS was a cross- 
sectional study, collecting data from 
health facilities in 29 countries in Africa, 
Asia, Latin America, and the Middle 
East, from May 2010–December 2011. 
Participating facilities and individuals
The majority of facilities in this anal-
ysis had participated in the previous 
WHO Global Survey on Maternal and 
Perinatal Health (10) and were included 
through a multistage random selection 
process. In each hospital, data collection 
took place during a 2–4-month period, 
depending on the number of annual de-
liveries in the health facility or group of 
health facilities selected in each country.
Three groups of women were eligible 
to participate in the WHO MCS: all those 
BOX 1. Stages of the Obstetric Transition 
•   Stage I (Maternal Mortality Ratio > 1 000 maternal deaths/100 000 live births): the majority of women 
experiences a situation close to the natural history of pregnancy and childbirth. Stage I is characterized 
by a very high maternal mortality ratio, with elevated fertility and the predominance of direct causes 
of maternal mortality, along with a large proportion of deaths attributable to communicable diseases, 
such as malaria. The majority of women do not receive professional obstetric care or do not have 
access to health facilities. 
•   Stage II (Maternal Mortality Ratio: 999 - 300 maternal deaths/100 000 live births): Mortality and fertility 
remain very high, with a pattern of causes similar to Stage I. However, a greater proportion of women 
start to seek and receive care in health units.
•   Stage III (Maternal Mortality Ratio: 299 - 50 maternal death/100 000 live births): Fertility is variable and 
direct causes of mortality still predominate. This is a complex stage, because access continues to be 
an issue for a large part of the population. However, since a high proportion of pregnant women arrive 
at health services, quality of care is one of the main determinants of health outcomes, particularly 
related to overburdened health services. Primary prevention, as well as secondary and tertiary 
prevention, is fundamental to improve maternal health outcomes in this stage. In other words, the 
quality of care, skilled childbirth care and adequate management of complications are essential for the 
reduction in maternal mortality.
•   Stage IV (MMR < 50 maternal deaths/100 000 live births): maternal mortality is low. There is a low 
fertility rate and indirect causes of maternal mortality, in particular chronic-degenerative diseases gain 
increasing importance. An aspect that emerges in this phase is the increasing role of medicalization 
as a threat to the quality and improvement of health outcomes. 
•  Stage V (all avoidable maternal deaths are actually prevented; maternal mortality ratio < 5 maternal 
deaths/100 000 live births). Maternal mortality is very low, the fertility rate is low or very low, and 
indirect obstetric causes associated with chronic-degenerative disorders are the main causes of 
maternal mortality. The main challenges in this stage are the consolidation of advances against 
structural violence (for example, gender inequalities), effective management of vulnerable populations 
(for example, immigrants, refugees and displaced people in their own country) and sustainability of 
excellence in quality of care.
Source: References 6 and 7. 
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admitted for childbirth at one of the se-
lected health units during data collection 
period; all women with severe maternal 
outcomes (SMO) classified as cases of 
maternal near-miss (MNM) associated 
with childbirth or abortion; and all ma-
ternal deaths. 
Data collection
The medical charts of all eligible 
women were reviewed until hospital 
discharge or until either the 7th day 
postpartum, abortion, or death, which-
ever occurred first. WHO criteria (11) 
were used to identify potentially life-
threatening conditions (PLTC) and 
MNM. Trained data collectors reviewed 
each chart on daily visits to each health 
unit facility, recording individual data 
on pregnancy outcome, severe compli-
cations, and clinical management. The 
paper form used for data collection had 
been previously pilot-tested. Data was 
coded and entered into an electronic 
data management system. Internal con-
sistency and random checks were per-
formed, comparing collected data, hos-
pital records, and electronic data. 
Data analysis
The demographic and obstetrics char-
acteristics of all women were described 
using simple frequencies and percent-
ages. WHO estimates of MMR were used 
to stratify participating countries into 
obstetric transition stages. Stage I was 
not used because none of the participat-
ing countries had MMR greater than 
1 000 deaths/ 100 000 LB. Stage V was 
also not used because it was considered 
a stage where MMR remained uncertain, 
idealized, and still theoretical (7). The 
frequency of women with PLTC (i.e., 
conditions that may lead to a maternal 
death) and SMO (i.e., MNM and mater-
nal deaths) was calculated according to 
the stages of obstetric transition. 
Due to lack of direct information, some 
characteristics of obstetric transition 
were evaluated through proxies. Con-
sidering the role of each characteristic in 
defining the obstetric transition concept, 
these proxies were selected a priori. Par-
ity served as a fertility proxy. The rate 
of cesarean delivery and labor induction 
served as proxies for medicalization of 
care. The frequency and ratio of uterine 
rupture were used as a proxy for avoid-
able causes of morbidity and mortality, 
since its occurrence is highly preventable 
by quality intrapartum monitoring and 
care. Simple frequencies were used to 
determine the prevalence of conditions 
selected. The mortality index—the num-
ber of maternal deaths divided by the 
number of women with severe maternal 
outcomes—was used an overall indica-
tor of quality of care (6). Subjects with 
missing data were not excluded and the 
total number available for each analysis 
is shown in tables. Statistical analysis 
was performed using SPSS software, 
version 21 (SPSS Inc., an IBM company, 
Chicago, Illinois, United States).
Ethics approval
The UNDP/UNFPA/UNICEF/WHO/
World Bank Special Program of Research, 
Development and Research Training in 
Human Reproduction (HRP) Special-
ist Panel on Epidemiological Research 
reviewed and approved the protocol 
of the WHO MCS for technical con- 
tent. The WHO MCS was approved 
by the WHO Ethical Review Commit-
tee and the relevant ethical clearance 
mechanisms in all countries (protocol 
ID: A65661; date of approval: 27 October 
2009). Formal authorization for study 
implementation was obtained from the 
Ministry of Health of each country, as 
well as from each participating facility. 
RESULTS
Data from 314 623 women admitted 
for childbirth by 359 health institutions 
in 29 countries were analyzed. After 
excluding the second or more newborns 
from multiple births, there were 306 771 
live births and 6 436 still births. Figure 1 
presents the analysis flow diagram. 
FIGURE 1. The Obstetric Transition Model in the World Health Organization Multicountry Survey 
(2010–2011): Analysis flow diagram
a Sum of live births and stillbirths does not equal the number of women because some women had abortions or  did not have 
a delivery.
b





























(306 771 infants born




n = 3 900 (3 664
infants born alive; 236
stillbirths)
– 29 countries
– 357 health facilities
– 314 623 women (310 435
   infants born alive; 6 672
   stillbirths)
WHO Multicountry Survey on
Maternal and Newborn Health
(2010–2011)
52 890 women161 145 women100 588 women
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Table 1 presents the demographic and 
obstetric characteristics of all the study 
participants. Most of the women (81%) 
were 20–35 years of age; almost 90% 
were living with a partner; 57% had 9 
years or more of schooling; 88% had 
never undergone a cesarean section; 77% 
had a spontaneous labor; 71% had a vag-
inal delivery; and 42% had no children, 
while 41% had 1–2 children. 
Table 2 presents the frequency of 
women according to maternal outcome 
and obstetric transition stage. It was 
observed that as the obstetric transition 
stage improved, there was a gradual in-
crease in PLTC (ranging from 70.1/1 000 
LB in Stage II to 101.8 in Stage IV), and 
marked reductions in MNM (ranging 
from 13.1/1 000 LB in Stage II to 4.2 
cases in Stage IV) and maternal death 
(ranging from 315 deaths/100 000 LB 
in Stage II to 13 in Stage IV). The mor-
tality index in Stage II was 17.6% (268 
deaths/1 525 women with severe ma-
ternal outcomes); 16.5% in Stage III 
(211 deaths/1 278 women); and 3.2% 
(3 deaths/221 women) in Stage IV. 
In the current database, most coun-
tries in Stage II are located in Africa, 
while most in Stage IV are in Asia. All 
Latin American countries in this data-
base were classified as Stage III, along 
with other Asian and Eastern Mediter-
ranean countries. 
Female fertility, indirectly estimated 
by parity, was higher in countries at a 
lower obstetric transition stage, rang-
ing from a mean of 3 children in Stage 
II to 1.8 children in Stage IV. The level 
of medicalization in health facilities 
in participating countries, defined by 
the number of cesarean deliveries and 
number of labor inductions, tended to 
increase as the stages of obstetric tran-
sition increased. In Stage IV, women 
had 2.4 times more cesarean deliveries 
(15.3%–36.7%) and 2.6 times more labor 
inductions (7.1%–18.8%) than women in 
Stage II. As the stages of obstetric tran-
sition increased, the mean age of pri-
miparous women also increased. The 
occurrence of uterine rupture had a de-
creasing trend for higher obstetric transi-
tion stages. Uterine rupture decreased 
by 5.2 times and its rate dropped from 
178 to 34 cases per 100 000 LB between 
Stages II and IV (Table 3).
TABLE 1. Demographic and obstetric characteristics of women in the World Health Organization Multicountry Survey on Maternal and Newborn 
Health (2010–2011) by stages of Obstetric Transition (OT)
                  Characteristic
All women OT Stage II OT Stage III OT Stage IV
No. % No. % No. % No. %
All women 314 623 100 100 588 32.0 161 145 51.2 52 890 16.8
Agea (years)
< 20 32 328 10.3 11 122 11.1 18 102 11.2 3 104 5.9
20–35 254 307 81.1 79 354 79.4 131 268 81.6 43 685 82.6
> 35 27 054 8.6 9 407 9.4 11 548 7.2 6 099 11.5
Subtotal 313 689 100.0 99 883 100.0 160 918 100.0 52 888 100.0
Marital statusa
Without partner 31 693 10.2 11 778 12.0 19 134 11.9 781 1.5
With partner 279 241 89.8 86 366 88.0 141 506 88.1 51 369 98.5
Subtotal 310 934 100.0 98 144 100.0 160 640 100.0 52 150 100.0
Schoolinga (years)
< 5 58 630 20.3 35 118 39.8 21 858 14.1 1 654 3.6
5–8 65 718 22.8 22 091 25.0 36 593 23.6 7 034 15.4
9–11 73 611 25.5 9 584 10.9 48 904 31.6 15 123 33.1
>11 90 816 31.4 21 415 24.3 47 590 30.7 21 811 47.8
Subtotal 288 775 100.0 88 208 100.0 154 945 100.0 45 622 100.0
Number of previous birthsa
0 132 672 42.3 31 412 31.4 75 510 46.9 25 750 48.7
1–2 130 245 41.5 37 384 37.3 69 324 43.1 23 537 44.5
> 2 51 052 16.3 31 336 31.3 16 117 10.0 3 599 6.8
Subtotal 313 969 100.0 100 132 100.0 160 951 100.0 52 886 100.0
Number of previous cesarean sectionsa
0 272 302 87.7 90 676 92.8 135 744 85.0 45 882 86.8
1 29 307 9.4 5 282 5.4 18 387 11.5 5 638 10.7
>1  8 746 2.8 1 804 1.8 5 611 3.5 1 331 2.5
Subtotal 310 355 100.0 97 762 100.0 159 742 100.0 52 851 100.0
Onset of labora
Spontaneous 241 724 77.3 86 797 87.2 123 228 76.9 31 699 60.0
Induced 32 784 10.5 7 088 7.1 15 757 9.8 9 939 18.8
No labor (cesarean section) 38 073 12.2 5 609 5.6 21 257 13.3 11 207 21.2
Subtotal 312 581 100.0 99 494 100.0 160 242 100.0 52 845 100.0
Mode of deliverya
Vaginal 223 145 71.4 84 050 84.5 105 690 65.9 33 405 63.2
Cesarean section 89 515 28.6 15 421 15.5 54 661 34.1 19 433 36.8
Subtotal 312 660 100.0 99 471 100.0 160 351 100.0 52 838 100.0
a
 Pearson Chi-Square test: P < 0.000.
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DISCUSSION
This study applied the obstetric transi-
tion concept to examine a large, multi-
country database of women who gave 
birth in health facilities. After country 
stratification by obstetric transition stage 
based on country-level MMR estimates 
(4), we found that as the stages of obstet-
ric transition increased, women tended 
to have fewer children, have the first 
child at an older age, and experience in-
creased medicalization of childbirth. The 
frequency of uterine rupture, used as a 
proxy for avoidable morbidity and mor-
tality, decreased as the obstetric transi-
tion stage increased. The frequency of 
severe maternal outcomes (both near-
miss and mortality) decreased in the 
study facilities as obstetric transition 
stage increased.
The Obstetric Transition Model was 
proposed as a theoretical framework that 
could provide a particular perspective 
for examining the dynamic process of 
maternal mortality reduction. This model 
allows identification of a country’s cur-
rent obstetric stage, which in turn can 
indicate which strategies should be used 
to make further improvements. Because 
this model considers specific features 
of the maternal population (such as fer-
tility, medicalization of pregnancy and 
childbirth, age of maternal population, 
and causes of maternal morbidity and 
mortality), it moves beyond human de-
velopment index classifications and pre-
vious transition models. The features 
of this model can provide guidance to 
public health decisionmakers on imple-
mentation of appropriate, dynamic, and 
efficient programs at the global, regional, 
and national levels (5).
Although the study findings corrobo-
rate the hypothesis of an ongoing ob-
TABLE 2. Frequency of women according to maternal outcome with potentially life-threatening conditions and severe maternal outcomes (maternal 
near miss and maternal deaths) and according to obstetric transition stage, World Health Organization Multicountry Survey on Maternal and 
Newborn Health (2010–2011)
Obstetric Transition
Hospitals All women Live births
Potentially life-
threatening conditionsa






    Country No. No. No. No. % No. % No. % No. IHMMRb
Stage II            
Afghanistan 8 26 148 25 227 923 36.6 440 17.4 421 16.7 19 75
Angola 20 10 450 9 966 587 58.9 92 9.2 57 5.7 35 351
DR Congo 21 8 756 8 395 501 59.7 115 13.7 88 10.5 27 322
Kenya 20 20 354 19 658 1 511 76.9 132 6.7 77 3.9 55 280
Niger 11 11 116 10 714 516 48.2 223 20.8 196 18.3 27 252
Nigeria 21 12 841 11 775 1 701 144.5 371 31.5 298 25.3 73 620
Uganda 21 10 923 10 467 691 66.0 152 14.5 120 11.5 32 306
Subtotal 122 100 588 96 202 6 430 70.1 1 525 16.2 1 257 13.1 268 315
Stage III            
Argentina 14 9 807 9 729 768 78.9 60 6.2 51 5.2 9 93
Brazil 7 7 058 7 019 505 71.9 18 2.6 17 2.4 1 14
Cambodia 5 4 725 4 635 288 62.1 64 13.8 59 12.7 5 108
Ecuador 18 10 245 10 108 1 429 141.4 39 3.9 30 3.0 9 89
Philippines 13 10 783 10 609 830 78.2 41 3.9 29 2.7 12 113
India 21 31 318 30 094 2 214 73.6 283 9.4 174 5.8 109 362
Jordan 1 1 167 1 158 119 102.8 5 4.3 5 4.3 0 0
Mexico 14 13 309 13 167 1 052 79.9 157 11.9 153 11.6 4 30
Mongolia 5 7 365 7 303 823 112.7 62 8.5 61 8.4 1 14
Nepal 8 11 290 10 999 363 33.0 73 6.6 65 5.9 8 73
Nicaragua 8 6 571 6 426 1 707 265.6 125 19.5 119 18.5 6 93
Pakistan 16 13 175 12 729 1 158 91.0 132 10.4 94 7.4 38 299
Peru 16 15 285 15 021 1 116 74.3 175 11.7 169 11.3 6 40
Paraguay 6 3 610 3 595 106 29.5 11 3.1 8 2.2 3 83
Viet Nam 15 15 437 15 411 138 9.0 33 2.1 33 2.1 0 0
Subtotal 167 161 145 158 003 12 616 86.9 1 278 7.8 1 067 6.9 211 94
Stage IV            
China 21 13 277 13 242 927 70.0 34 2.6 34 2.6 0 0
Japan 10 3 537 3 527 655 185.7 21 6.0 21 6.0 0 0
Lebanon 9 4 044 4 008 210 52.4 20 5.0 18 4.5 2 50
Sri Lanka 14 18 129 17 988 862 47.9 76 4.2 73 4.1 3 17
OPT c 1 980 975 150 153.8 3 3.1 3 3.1 0 0
Qatar 1 3 950 3 932 509 129.5 14 3.6 14 3.6 0 0
Thailand 12 8 973 8 894 656 73.8 53 6.0 51 5.7 2 22
Subtotal 68 52 890 52 566 3 969 101.8 221 4.3 214 4.2 7 13
Overall 357 314 623 306 771 23 015 86.2 3 024 7.3 2 538 8.0 486 140
a The prevalence of women with potentially life-threatening conditions. women with severe maternal outcomes and maternal near miss cases are calculated per 1 000 live births.
b IHMMR: intra-hospital maternal mortality ratio, limited to the first week following pregnancy termination and calculated per 100 000 live births.
c OPT: Occupied Palestinian Territory.
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stetric transition, some aspects deserve 
further exploration. At first glance, the 
higher prevalence of potentially life-
threatening conditions observed in the 
more advanced stages of obstetric tran-
sition seem counterintuitive. However, 
this higher prevalence may actually sug-
gest more thorough surveillance and a 
greater capacity to diagnose pregnancy 
complications, such as pre-eclampsia, 
postpartum hemorrhage, and indirect 
complications. Deaths caused by pre- 
eclampsia and postpartum hemorrhage 
are largely preventable, but early di-
agnosis may be challenging in under-
resourced settings. For example, if birth 
assistants are overwhelmed with patients 
and lack conditions and resources to offer 
appropriate care, some cases of mild pre-
eclampsia or postpartum hemorrhage 
may not be detected, leading to a false 
low PLTC prevalence. In part, this is why 
we used uterine rupture as a proxy for 
avoidable causes of maternal deaths: this 
complication is clearly preventable and 
rarely overlooked. Although more re-
lated to intrapartum care and the ability 
to detect and manage obstructed labor, 
we considered uterine rupture a more 
stable indicator for studying the relation-
ship between obstetric transition stages 
and the occurrence of preventable causes 
of maternal mortality. Mortality among 
cases presenting with severe maternal 
outcomes (i.e., the SMO mortality index) 
could also provide some understanding 
of the role of quality of care in the obstet-
ric transition (11). Our findings suggest 
that poor quality of care and difficulties 
in managing severe complications are a 
relevant issue at early stages of the ob-
stetric transition.
One of the challenges of maternal 
mortality reduction is that sustainable 
and impactful solutions are needed be-
yond the health sector, and often require 
an intersectoral approach for health and 
social development (3, 12–14). In part, 
this is the reason why the MMR was se-
lected as a development indicator as part 
of the MDG. Most maternal deaths take 
place in low-income countries. Reduc-
tion requires effective public policies that 
transcend the health sector. Intersectoral 
actions, such as health, social, economic, 
cultural, and environmental policies are 
needed to induce social development, 
and result in a global maternal mortality 
reduction (3, 5, 12–14).
In the health sector, several strategies 
may be used concurrently to reduce 
preventable maternal mortality. These 
include adequate emergency obstet-
ric care; functioning referral systems; 
available blood transfusion; effective 
medicines and obstetric surgery; family 
planning; contraception; high-quality, 
humane care during pregnancy, child-
birth, and the postpartum period; access 
to safe abortion; adequate equipment 
and skilled personnel; and health infor-
mation and surveillance systems with 
the appropriate registration of maternal 
death and near-miss cases and the study 
of their causes (5). 
Although all countries participating 
in the WHO MCS showed a downward 
MMR trend in 1990–2013, the highly 
significant difference in rates between 
countries highlights the underlying so-
cial inequity in the world (4, 9; see 
Supplementary material that chart MMR 
trends by obstetric transition stage). 
These inequities also occur within coun-
tries, where vulnerable populations (i.e., 
the economically-disadvantaged, those 
with few years of education, racial and 
ethnic minorities, refugees, indigenous 
people) suffer most. These groups and 
communities suffer the effects of struc-
tural violence (e.g., institutionalized 
racism or sexism that prevent certain 
people from meeting their basic needs 
and/or achieving their potential) that 
can culminate in avoidable death or 
morbidity (3, 12–14). 
We also observed some variation in 
the obstetric transition status accord-
ing to the country’s geographic loca-
tion, emphasizing the need to customize 
strategies. Thus, while in most African 
countries great emphasis should be di-
TABLE 3. Obstetric transition stages and their characteristics in the World Health Organization Multicountry 
Survey on Maternal and Newborn Health (2010–2011) 
Characteristic Stage II Stage III Stage IV Overall
All women 100 588 161 145 52 890 314 623
Live births (LB)   96 202 158 003 52 566 306 771
Maternal mortalitya
Intra-hospital maternal deaths /100 000 LB 279 134 13 158
Number of maternal deaths 268 211  7 486
Fertility (proxy) a
Parity (± Standard Deviation [SD]) 3.0 (±2.2) 2.0 (± 1.3) 1.8 (± 1.1) 2.3 (±1.7)
Medicalization (proxy)b
Cesarean section rate 









Inductions of labor rate 









Age of maternal population (proxy)a 
Age of nulliparous in years (±  SD) 22.3 (± 4.7) 23.4 (± 5.0) 25.8 (± 5.3) 23.6 (±5.1)
Avoidable morbidity & mortality (proxy)b
Ruptured uterus per 100 000 LB 178  80 34  86
Number of ruptured uterus 171 127 18 316
a
 P < 0.000 (Pearson Chi-Square test).
b
 P < 0.000 (ANOVA).
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rected to strengthening basic social and 
health infrastructure, in Asia and Latin 
America further reductions in maternal 
mortality may be largely dependent on 
improvements in quality of care. It is 
important to note that this analysis was 
conducted at a high level with a lens 
on certain aspects, however, all aspects 
remain important and should not be 
overlooked.
Limitations
This analysis presents both strengths 
and limitations of note. The size and 
breadth of the database allowed the 
obstetric transition concept to be ex-
plored on a global scale for the first time. 
However, the study’s cross-sectional de-
sign, the source of data (routine medical 
records), and the ecological approach 
limited the level of evidence that could 
be generated. Other limitations include 
the use of proxies to study some charac-
teristics of the obstetric transition. Also, 
one must consider that the obstetric 
transition is the product of complex in-
teractions of social, economic, cultural, 
biological, and health forces, among oth-
ers, and that these interactions have im-
plications that go far beyond the health 
sector. 
Conclusions
This analysis supports the theory of 
obstetric transition using multicountry 
data. The study findings demonstrated 
that the Obstetric Transition Model can 
be used to justify customizing solu-
tions for maternal mortality reduction 
by aligning with a country’s stage in 
the obstetric transition. Promoting so-
cial development and equity, together 
with health system strengthening and 
improvements in quality of care, are 
necessary actions for avoiding maternal 
deaths that may be more effectively 
and efficiently applied when a country’s 
stage in the transition is known. Future 
research could explore population-based 
data (e.g., demographic health surveys) 
to further understand the obstetric tran-
sition concept.
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Objetivo. Evaluar si las características propuestas del Modelo de Transición Obsté-
trica, un marco teórico que puede explicar los cambios graduales que experimentan 
los países a medida que eliminan la mortalidad materna evitable, se pueden observar 
en una amplia base de datos de salud materna y perinatal de varios países; y tratar 
sobre el proceso dinámico de reducción de la mortalidad materna utilizando este 
modelo como marco teórico. 
Métodos. Este estudio consistió en un análisis secundario de un estudio transversal 
realizado por la Organización Mundial de la Salud que recopiló información sobre 
más de 300 000 mujeres que dieron a luz en 359 establecimientos de salud de 29 países 
de África, Asia, América Latina y Oriente Medio, durante un período de 2 a 4 meses 
en el 2010 y el 2011. Se calcularon los índices de afecciones potencialmente mortales, 
resultados maternos graves, morbilidad materna extremadamente grave, y muerte 
materna, y se estratificaron según las etapas de transición obstétrica. Se definen las 
características de cada etapa. 
Resultados. Los datos de 314 623 mujeres indicaron que la fecundidad femenina, 
calculada indirectamente por el número de partos, fue mayor en los países que se 
hallaban en las primeras etapas de la transición obstétrica, desde un promedio de 3 
hijos en el estadio II a 1,8 en el estadio IV. El nivel de medicalización de los estableci-
mientos de salud de los países participantes, definido por el número de partos por 
cesárea y el número de partos inducidos, tuvo tendencia a aumentar según avanzaba 
la etapa de transición obstétrica. En el estadio IV, las mujeres tuvieron 2,4 veces más 
partos por cesárea (15,3% en el estadio II y 36,7% en el estadio IV) y 2,6 veces más 
inducciones de parto (7,1% en el estadio II y 18,8% en el estadio IV) que las mujeres 
en el estadio II. A medida que avanzaban las etapas de transición obstétrica, también 
se incrementaba la media de edad de las mujeres primíparas. La ocurrencia de rotura 
uterina mostraba una tendencia descendente, y se reducía 5,2 veces, de 178 a 34 casos 
por 100 000 nacidos vivos, a medida que un país efectuaba la transición del estadio 
II al IV. 
Conclusiones. Este análisis apoya el concepto de transición obstétrica utilizando datos 
de varios países. El Modelo de Transición Obstétrica podría justificar la adaptación 
de las estrategias para reducir la mortalidad materna según la etapa de transición 
obstétrica en que se halla un país. 
Salud de la mujer; mortalidad materna, tendencias; complicaciones del trabajo de 
parto; bienestar materno; salud global; Organización Mundial de la Salud.
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